Numerical decreases in DAS28‐CRP were observed in patients with PsA, although this did not reach statistical significance, potentially due to the limited number of patients (Figure 5d–f ).
← all excerpts
Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.
1
—
—